Taysha Gene Therapies, Inc. - 10-Q Filing

Taysha Gene Therapies reports Q3 financial results featuring significant research and development activity and ongoing debt obligations related to Trinity Term Loans.

2 articles from 1 source · updated November 12, 2026, 12:38 UTC

Coverage

• Taysha Gene Therapies, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 12:38 UTC
• Taysha Gene Therapies, Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 12:30 UTC